PSORIASIS
Clinical trials for PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS trials appear
Sign up with your email to follow new studies for PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Psoriasis combo therapy falls short: study halted early
Disease control TerminatedThis study looked at whether adding low-dose methotrexate to standard anti-TNF treatment could help adults with moderate to severe psoriasis achieve and maintain better skin clearance. The trial planned to enroll 78 participants but was terminated early. The goal was to see if th…
Matched conditions: PSORIASIS
Phase: PHASE4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
New drug for skin conditions shows early promise in safety trial
Symptom relief TerminatedThis early-stage study tested a new drug called XmAb27564 in 23 people with plaque psoriasis or atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when given as multiple injections. The study was stopped early, so results are limited.
Matched conditions: PSORIASIS
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Symptom relief
Last updated May 26, 2026 02:45 UTC
-
Psoriasis study probes Insulin's hidden role in skin flares
Knowledge-focused TerminatedThis study looked at whether insulin works differently in psoriasis skin patches compared to healthy skin. Ten adults with plaque psoriasis and overweight or prediabetes had small skin samples taken before and after a sugar drink. Researchers measured how skin cells respond to in…
Matched conditions: PSORIASIS
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 26, 2026 02:55 UTC